Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$51.15 - $56.52 $156,519 - $172,951
3,060 Added 6.34%
51,290 $2.75 Million
Q4 2023

Feb 14, 2024

SELL
$43.79 - $55.14 $1.66 Million - $2.09 Million
-37,822 Reduced 43.95%
48,230 $2.57 Million
Q3 2023

Nov 14, 2023

SELL
$49.1 - $62.37 $5.9 Million - $7.49 Million
-120,071 Reduced 58.25%
86,052 $4.27 Million
Q2 2023

Aug 14, 2023

BUY
$52.61 - $59.54 $8.19 Million - $9.27 Million
155,621 Added 308.15%
206,123 $12.3 Million
Q1 2023

May 15, 2023

BUY
$51.83 - $79.63 $677,521 - $1.04 Million
13,072 Added 34.92%
50,502 $2.86 Million
Q4 2022

Feb 14, 2023

BUY
$58.4 - $75.53 $1.64 Million - $2.12 Million
28,071 Added 299.94%
37,430 $2.78 Million
Q3 2022

Nov 14, 2022

BUY
$55.32 - $67.54 $517,739 - $632,106
9,359 New
9,359 $585,000

Others Institutions Holding GMED

About GLOBUS MEDICAL INC


  • Ticker GMED
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 77,037,200
  • Market Cap $6.3B
  • Description
  • Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...
More about GMED
Track This Portfolio

Track Amundi Portfolio

Follow Amundi and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.